RASILEZ

This brand name is authorized in Austria, Canada, Croatia, Cyprus, Estonia, France, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, South Africa, Spain, UK.

Active ingredients

The drug RASILEZ contains one active pharmaceutical ingredient (API):

1	Aliskiren UNII C8A0P8G029 - ALISKIREN HEMIFUMARATE
	Aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin. By inhibiting the enzyme renin, aliskiren inhibits the RAAS at the point of activation, blocking the conversion of angiotensinogen to angiotensin I and decreasing levels of angiotensin I and angiotensin II.
	Read more about Aliskiren

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RASILEZ Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09XA02	Aliskiren	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09X Other agents acting on the renin-angiotensin system → C09XA Renin-inhibitors
Discover more medicines within C09XA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02302063, 02302071
EE	Ravimiamet	1307023, 1307034, 1307045, 1307056, 1307067, 1307078, 1307089, 1307090, 1307102, 1307113, 1307124, 1307135, 1307146, 1307157, 1307168, 1307179, 1307180, 1307191, 1307203, 1307214
ES	Centro de información online de medicamentos de la AEMPS	07405022, 07405032
FR	Base de données publique des médicaments	61195604, 61280428
GB	Medicines & Healthcare Products Regulatory Agency	119610, 119618, 175904, 178849, 180663, 186092, 186094, 375325, 375328
HK	Department of Health Drug Office	60309, 60310
IE	Health Products Regulatory Authority	68210, 68211, 68250, 68255, 68280, 68281
IT	Agenzia del Farmaco	038243010, 038243022, 038243034, 038243046, 038243059, 038243061, 038243073, 038243085, 038243097, 038243109, 038243111, 038243123, 038243135, 038243147, 038243150, 038243162, 038243174, 038243186, 038243198, 038243200, 038243212, 038243224, 038243236, 038243248, 038243251, 038243263, 038243275, 038243287, 038243299, 038243301, 038243313, 038243325, 038243337, 038243349, 038243352, 038243364, 038243376, 038243388, 038243390, 038243402
JP	医薬品医療機器総合機構	2149047F1028
LT	Valstybinė vaistų kontrolės tarnyba	1030623, 1030624, 1030625, 1030626, 1030627, 1030628, 1030629, 1030630, 1030631, 1030632, 1030633, 1030634, 1030635, 1030636, 1030637, 1030638, 1030639, 1030640, 1030641, 1030642, 1056696, 1056697, 1056698, 1056699, 1056700, 1056701, 1056702, 1056703, 1056704, 1056705, 1056706, 1056707, 1056708, 1056709, 1056710, 1056711, 1056712, 1056713, 1056714, 1056715
NL	Z-Index G-Standaard, PRK	85065, 85073
PL	Rejestru Produktów Leczniczych	100147757, 100178657
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W52241001, W52241002, W52241003, W52241004, W52241005, W52241006, W52241007, W52241008, W52241009, W52241010, W52242001, W52242002, W52242003, W52242004, W52242005, W52242006, W52242007, W52242008, W52242009, W52242010
ZA	Health Products Regulatory Authority	41/7.1.3/0971, 41/7.1.3/0972